US FDA Provides ‘Closeout Letters’ to Warning Letter Recipients

International Pharmaceutical Regulatory Monitor
A A
Drugmakers that have resolved issues in warning letters from the U.S. Food and Drug Administration (FDA) dated Sept. 1 or later — and have passed inspections that verify the corrective action — are eligible for closeout letters.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $20.00